Gabriel Brooks

Associate Professor

United States

Research Interests

Explore related searches

Professors in United States Professors in Pharmacy Pharmacy professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Gabriel Brooks is an Associate Professor at Dartmouth Cancer Center in the United States. His research areas include the impact of healthcare delivery models on oncology outcomes, rural healthcare access, and the implications of biological factors on cancer treatment. Dr. Brooks has published extensively on topics such as disparities in cancer care, cost-effectiveness in treatment strategies, and innovative approaches to enhance patient quality of life.

Articles (19)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (6)

John Bridgewater

UCL Cancer Institute

UNITED KINGDOM

View details

Tracy Onega

UNITED STATES

View details

James O'Malley

Professor of Biostatistics

Dartmouth College Geisel School of Medicine

UNITED STATES

View details

Daniel Hertz

University of Michigan

UNITED STATES

View details

Fahui Wang

UNITED STATES

View details

Changzhen Wang

Dean's Postdoctoral Research Associate

The University of Alabama

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Gabriel Brooks

Research Interests

Explore related searches

Contact this professor

About

Articles (19)

Rural Oncologists' Perceptions of Specialty Scarcity and Repercussions for Care Delivery: A Qualitative Study

Oncology Care Model and Ripple Effects of Value-Based Care

A pragmatic, single-arm clinical trial of a dose modification algorithm for preventing cytopenia-related delays during FOLFOX chemotherapy

Hidden figures underlying quality measures: revealing hidden racial inequalities in end-of-life cancer care delivery: a cohort study

Travel burden and bypassing closest site for surgical cancer treatment for urban and rural oncology patients

Characterizing the Traveling Oncology Workforce and Its Influence on Patient Travel Burden: A Claims-Based Approach

Biological sex and chemotherapy treatment delays in patients with colorectal cancer

Association between a network-based physician linchpin score and cancer patient mortality: a SEER-Medicare analysis

Implementation of a pharmacist-guided pharmacogenomics dosing service at a rural NCI-designated comprehensive cancer center

More Drugs Versus More Data: The Tug of War on Cancer in Low- and Middle-Income Countries

DPYD Testing: Time to Put Patient Safety First

Association of rurality, socioeconomic status, and race with pancreatic cancer surgical treatment and survival

Comparison of Oncologist and Model Estimates of Risk for Hospitalization During Systemic Therapy for Advanced Cancer

Telehealth Use Following COVID-19 Within Patient-Sharing Physician Networks at a Rural Comprehensive Cancer Center: Cross-sectional Analysis

Risk Stratification for Patients With Cancer and Febrile Neutropenia: Art or Science?

Cost-effectiveness of DPYD Genotyping Prior to Fluoropyrimidine-based Adjuvant Chemotherapy for Colon Cancer

Impact of the Oncology Care Model on Use of Supportive Care Medications During Cancer Treatment

Development of dynamic health care delivery heatmaps for end-of-life cancer care: a cohort study

Revisiting UGT1A1 Pharmacogenetic Testing Before Irinotecan—Why Not?

Collaborators (6)

John Bridgewater

Tracy Onega

James O'Malley

Daniel Hertz

Fahui Wang

Changzhen Wang

Make your next move.